Rate of caesarean section is alarming in China

The Lancet (Impact Factor: 45.22). 04/2014; 383(9927):1463-4. DOI: 10.1016/S0140-6736(14)60716-9
Source: PubMed
Download full-text


Available from: Fangchao Liu, Jul 18, 2014
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: To obtain a general overview of infant and young child feeding practices in one rural county in China and identify current delivery channels and challenges.
    BMJ Open 07/2014; 4(7):e005108. DOI:10.1136/bmjopen-2014-005108 · 2.06 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background The outcomes of pregnancy in immunoglobulin A nephropathy (IgAN) are uncertain. This study assessed the effects of pregnancy on kidney disease progression and risk factors for adverse pregnancy outcomes in IgAN. Study Design A matched-cohort study. Setting & Participants Women with IgAN with at least one pregnancy, 1 year of follow-up, and kidney function and proteinuria measurement at baseline (time of biopsy) matched with nonpregnant women with IgAN from Peking University First Hospital. Predictors Pregnancy, treated as a time-dependent variable; proteinuria; hypertension; and estimated glomerular filtration rate (eGFR). Outcomes Kidney disease progression, defined as eGFR halving or end-stage kidney disease; rate of eGFR decline; and adverse pregnancy outcomes, including severe pre-eclampsia, intrauterine death, embryo damage, fetal malformation, and induced and spontaneous abortions. Results Of 239 female patients, 62 women had 69 pregnancies and 62 matched nonpregnant patients were selected as controls. Pregnant patients had median proteinuria at baseline with protein excretion of 1.27 (range, 0.06-7.25) g/d and mean eGFR of 102.3 (range, 40.0-139.0) mL/min/1.73 m2. During a mean follow-up of 45.7 months, 4 patients in the pregnancy group and 6 in the nonpregnancy group had kidney disease progression events. Time-dependent Cox analysis showed that pregnancy was not an independent risk factor for kidney disease progression events (HR, 1.2; 95% CI, 0.3-5.7). There was no significant difference in the median rate of eGFR decline in the 2 groups (−2.5 vs −2.4 mL/min/1.73 m2 per year; P = 0.7). Adverse pregnancy outcomes were observed in 15 patients. Proteinuria during pregnancy (OR, 1.39; 95% CI, 0.96-2.01) was a borderline predictor of adverse pregnancy outcomes. Limitations Retrospective study, most patients had preserved kidney function, study underpowered to detect a difference in kidney failure events. Conclusions The study does not permit a definitive conclusion about the effect of pregnancy on kidney disease progression in IgAN.
    American Journal of Kidney Diseases 11/2014; 64(5). DOI:10.1053/j.ajkd.2014.06.021 · 5.76 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: As most pregnancy-related deaths and morbidities are clustered around the time of childbirth, quality of care during this period is critical to the survival of pregnant women and their babies. Despite the wide acceptance of partograph as the central tool to optimize labour outcomes for over 40 years, its use has not successfully improved outcomes in many settings for several reasons. There are also increasing questions about the validity and applicability of its central feature – “the alert line” – to all women regardless of their labour characteristics. Apart from the known deficiencies in labour care, attempts to improve quality of care in low resource settings have also failed to address and integrate women’s birth experience into quality improvement processes. It was against this background that the World Health Organization (WHO) embarked on the Better Outcomes in Labour Difficulty (BOLD) project to improve the quality of intrapartum care in low- and middle-income countries. The main goal of the BOLD project is to reduce intrapartum-related stillbirths, maternal and newborn mortalities and morbidities by addressing the critical barriers to the process of good quality intrapartum care and enhancing the connection between health systems and communities. The project seeks to achieve this goal by (1) developing an evidence-based, easy to use, labour monitoring-to-action decision-support tool (currently termed Simplified, Effective, Labour Monitoring-to-Action – SELMA); and (2) by developing innovative service prototypes/tools, co-designed with users of health services (women, their families and communities) and health providers, to promote access to respectful, dignified and emotionally supportive care for pregnant women and their companions at the time of birth (“Passport to Safer Birth”). This two-pronged approach is expected to positively impact on important domains of quality of care relating to both provision and experience of care. In this paper, we briefly describe the rationale for innovative thinking in relation to improving quality of care around the time of childbirth and introduce WHO current plans to improve care through research, design and implementation of innovative tools and services in the post-2015 era. Please see related articles ‘’ and ‘’.
    Reproductive Health 05/2015; 12(48). DOI:10.1186/s12978-015-0027-6 · 1.62 Impact Factor